Acadia Pharmaceuticals

IPO

Meaningful innovation for underserved communities

Public · San Diego, United States · Founded 1993 · $36.0M raised

Employees
501–1000
Founded
1993
Business Model
Other
Website
acadia.com
Total Funding
$36.0M
Last Round
$36.0M Corporate RoundMar 2005
Rounds
2
Type
Public

About

Acadia Pharmaceuticals is a biopharmaceutical company that developed the first and only treatment for hallucinations and delusions associated with Parkinson's disease psychosis and commercialized the first therapy for Rett syndrome. The company serves patients living with neurological disorders and rare diseases through a proven commercial portfolio and a diverse pipeline of investigational therapies. Rooted in groundbreaking science, Acadia is positioned to lead the next era of therapeutic innovation for conditions with significant unmet medical need.

Summary

Acadia Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 1993. It has raised $36.0M in total across 2 rounds, most recently a $36.0M Corporate Round in Mar 2005. Investors include Nasdaq Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMar 2005
$36.0M

Sign up to see all 3 events

Funding: Series F through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Acadia Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/acadia-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/acadia-pharmaceuticals" alt="Acadia Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>